Predicting Progression of Developing Myeloma in a High-Risk Screened Population

NARecruitingINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2028

Conditions

Healthy

Interventions

DIAGNOSTIC_TEST

blood sampling

Participants will provide a blood sample that will be used to determine whether they have a monoclonal protein

Trial Locations (1)

RECRUITING

TASMC, Tel Aviv

All Listed Sponsors

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV